Nonlinear association of physical activity with early cardiovascular-kidney-metabolic syndrome risk: a comprehensive analysis of NHANES data from 2007 to 2018
- PMID: 40437440
- PMCID: PMC12117810
- DOI: 10.1186/s12889-025-23157-6
Nonlinear association of physical activity with early cardiovascular-kidney-metabolic syndrome risk: a comprehensive analysis of NHANES data from 2007 to 2018
Abstract
Background: Cardiovascular-kidney-metabolic (CKM) syndrome, a newly defined cluster of interrelated cardiometabolic disorders, poses a global health burden. While physical activity (PA) is a cornerstone of metabolic health, its relationship with early CKM progression remains unclear. This study aims to explore the nonlinear dose-response evidence between PA and early CKM syndrome and highlights the potential PA thresholds to maximise metabolic health benefits, providing theoretical support for personalized PA guidelines.
Methods: Using data from the National Health and Nutrition Examination Survey (NHANES) 2007-2018, we analyzed 12,068 participants with early CKM (stages 0-2). Moderate-to-vigorous physical activity (MVPA) was quantified as metabolic equivalent of task (MET)*min/week. Restricted cubic splines, weighted logistic regression, and mediation analyses were employed to assess MVPA-CKM relationships and mediating roles of obesity-related indicators. Subgroup analyses evaluated heterogeneity across demographics and other core covariates.
Results: A L-shaped association between MVPA and early CKM risk was identified (p-non-linear < 0.001). Before the lowest point (6872 MET*min/week), any incremental increase in MVPA was associated with a reduction in early CKM risk, and moderate MVPA (600 - 12,600 MET*min/week) exerts a protective effect. Up to the threshold of 12,600 MET*min/week, MVPA continued to exhibit protective effects. The mediating effect of all the obesity-related indicators was not significant (p > 0.05). Protective effects of moderate PA were consistent across the majority subgroups, whereas an attenuation or even reversal of this protective effect was observed at excessive MVPA levels (> 12,600 MET*min/week), where outcomes statistically indistinguishable from those observed at MVPA levels below 600 MET*min/week.
Conclusions: This study reveals an L-shaped association between MVPA and early CKM risk. The findings highlight the protective effects of moderate MVPA (600 - 12,600 MET*min/week) while demonstrating that higher MVPA (> 12,600 MET*min/week) may attenuate or even reverse these benefits.
Keywords: Cardiovascular-kidney-metabolic syndrome; National health and nutrition examination survey (NHANES); Physical activity.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Data collection for the NHANES was approved by the NCHS Research Ethics Review Board (ERB). An individual investigator utilizing the publicly available NHANES data does not need to file the institution internal review board (IRB). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Nonlinear dose-response association of moderate-to-vigorous physical activity with hyperuricemia in US adults: NHANES 2007-2018.PLoS One. 2024 May 23;19(5):e0302410. doi: 10.1371/journal.pone.0302410. eCollection 2024. PLoS One. 2024. PMID: 38781249 Free PMC article.
-
Insulin resistance mediates the association between physical activity and mortality in US adults with metabolic syndrome.Sci Rep. 2025 May 29;15(1):18872. doi: 10.1038/s41598-025-02921-z. Sci Rep. 2025. PMID: 40442162 Free PMC article.
-
The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies.Cardiovasc Diabetol. 2025 Mar 24;24(1):137. doi: 10.1186/s12933-025-02689-6. Cardiovasc Diabetol. 2025. PMID: 40128747 Free PMC article.
-
Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome.Cardiovasc Diabetol. 2025 Apr 26;24(1):183. doi: 10.1186/s12933-025-02742-4. Cardiovasc Diabetol. 2025. PMID: 40287685 Free PMC article.
-
An overview of cardiovascular-kidney-metabolic syndrome.Am J Manag Care. 2024 Dec;30(10 Suppl):S181-S188. doi: 10.37765/ajmc.2024.89670. Am J Manag Care. 2024. PMID: 39705194 Review.
Cited by
-
Distinct metabolic syndrome profiles across Asian American subpopulations.Sci Rep. 2025 Aug 12;15(1):29518. doi: 10.1038/s41598-025-15183-6. Sci Rep. 2025. PMID: 40797017 Free PMC article.
References
-
- Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Després JP, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) syndrome: A scientific statement from the American heart association. Circulation. 2023;148(20):1636–64. - PubMed
-
- Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, et al. Cardiovascular-Kidney-Metabolic health: A presidential advisory from the American heart association. Circulation. 2023;148(20):1606–35. - PubMed
-
- Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, Grandner MA, Lavretsky H, Perak AM, Sharma G, et al. Life’s essential 8: updating and enhancing the American heart association’s construct of cardiovascular health: A presidential advisory from the American heart association. Circulation. 2022;146(5):e18–43. - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous